Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/bf01834624.

Title:
Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma | Breast Cancer Research and Treatment
Description:
The involvement of lipid enzymes in the action of oncogenes at the cell membrane level has suggested that membrane lipids could play a role in modulating the growth of tumors. We previously found that breast cancer patients with a low level of polyunsaturated fatty acids in their primary tumor
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Education
  • Environment

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

cancer, google, scholar, breast, pubmed, acid, article, phosphatidylcholine, fatty, stearic, patients, tumor, level, membrane, metastasis, bougnoux, lanson, acids, composition, access, res, fat, human, privacy, cookies, content, research, prognostic, carcinoma, lipid, lipids, dietary, france, publish, search, significance, couet, cell, tumors, natl, inst, carcinogenesis, tours, analysis, data, information, log, journal, chajes, role,

Topics {✒️}

activated c-h-ras oncogene month download article/chapter independent intra-tumor marker polyunsaturated fatty acids specific fatty acids fatty acid composition stearic acid level related subjects privacy choices/manage cookies fatty acids full article pdf cell membrane level human breast cancer membrane lipid composition breast cancer patients membrane phospholipids faculté de médecine cell transformation induced diaz-meco mt pai h-lh adipose tissue composition human breast carcinoma breast cancer prognosis remained metastasis-free capillary gas chromatography carcinoma tissue obtained node-positive patients node-negative patients european economic area high mitotic index ha-ras oncogene estrogen receptor assays boron fluoride-methanol human colostrum triglycerides centre rené-huguenin tumor membrane phosphatidylcholine check access instant access conditions privacy policy phosphatidylcholine-hydrolyzing phospholipase stearic acid accepting optional cookies gilles body epidermal-growth-factor breast cancer dietary fat consumption journal finder publish kamel hacene wood cb low level

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma
         description:The involvement of lipid enzymes in the action of oncogenes at the cell membrane level has suggested that membrane lipids could play a role in modulating the growth of tumors. We previously found that breast cancer patients with a low level of polyunsaturated fatty acids in their primary tumor's phosphatidylethanolamine had a high risk of early occurrence of visceral metastasis. In the present study, we prospectively examined whether fatty acid composition of tumor membrane phosphatidylcholine had a prognostic significance in a series of 63 patients with a localized presentation of breast cancer. Membrane phospholipids were extracted from the carcinoma tissue obtained at the time of surgery, phosphatidylcholine was purified, and its fatty acids were analyzed by capillary gas chromatography. During the follow-up period, 20 patients developed metastasis. In these patients, the proportion of stearic acid containing phosphatidylcholine was significantly lower than it was in the tumors of the 43 patients who remained metastasis-free. Multivariate analysis according to Cox showed that low stearic acid level in tumor phosphatidylcholine and high mitotic index were independently predictive of subsequent metastasis. The predictive value of stearic acid level on metastasis risk was higher in node-positive patients than in node-negative patients, allowing individualization of a subgroup of low stearic acid level, node-positive patients with very poor prognosis. We concluded that stearic acid level in tumor membrane phosphatidylcholine is an independent intra-tumor marker of breast cancer prognosis. This finding is new evidence that tumor's structural lipids are linked to the growth of breast cancer.
         datePublished:
         dateModified:
         pageStart:185
         pageEnd:194
         sameAs:https://doi.org/10.1007/BF01834624
         keywords:
            breast cancer
            metastasis
            phospholipids
            fatty acids
            stearic acid
            Oncology
         image:
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:20
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Philippe Bougnoux
               affiliation:
                     name:CNRS URA 1334 et Faculté de Médecine
                     address:
                        name:Laboratoire de Biologie des Tumeurs, CNRS URA 1334 et Faculté de Médecine, Tours cedex, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Véronique Chajes
               affiliation:
                     name:CNRS URA 1334 et Faculté de Médecine
                     address:
                        name:Laboratoire de Biologie des Tumeurs, CNRS URA 1334 et Faculté de Médecine, Tours cedex, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Monique Lanson
               affiliation:
                     name:CNRS URA 1334 et Faculté de Médecine
                     address:
                        name:Laboratoire de Biologie des Tumeurs, CNRS URA 1334 et Faculté de Médecine, Tours cedex, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kamel Hacene
               affiliation:
                     name:Centre René-Huguenin
                     address:
                        name:Dept. de Biostatistiques, Centre René-Huguenin, Saint-Cloud, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gilles Body
               affiliation:
                     name:CHU
                     address:
                        name:Clinique Gynécologique et Obstétricale, CHU, Tours, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Charles Couet
               affiliation:
                     name:CHU
                     address:
                        name:Laboratoire de Nutrition, CHU, Tours, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Olivier Le Floch
               affiliation:
                     name:CHU
                     address:
                        name:Clinique d'Oncologie et Radiothérapie, CHU, Tours, France
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma
      description:The involvement of lipid enzymes in the action of oncogenes at the cell membrane level has suggested that membrane lipids could play a role in modulating the growth of tumors. We previously found that breast cancer patients with a low level of polyunsaturated fatty acids in their primary tumor's phosphatidylethanolamine had a high risk of early occurrence of visceral metastasis. In the present study, we prospectively examined whether fatty acid composition of tumor membrane phosphatidylcholine had a prognostic significance in a series of 63 patients with a localized presentation of breast cancer. Membrane phospholipids were extracted from the carcinoma tissue obtained at the time of surgery, phosphatidylcholine was purified, and its fatty acids were analyzed by capillary gas chromatography. During the follow-up period, 20 patients developed metastasis. In these patients, the proportion of stearic acid containing phosphatidylcholine was significantly lower than it was in the tumors of the 43 patients who remained metastasis-free. Multivariate analysis according to Cox showed that low stearic acid level in tumor phosphatidylcholine and high mitotic index were independently predictive of subsequent metastasis. The predictive value of stearic acid level on metastasis risk was higher in node-positive patients than in node-negative patients, allowing individualization of a subgroup of low stearic acid level, node-positive patients with very poor prognosis. We concluded that stearic acid level in tumor membrane phosphatidylcholine is an independent intra-tumor marker of breast cancer prognosis. This finding is new evidence that tumor's structural lipids are linked to the growth of breast cancer.
      datePublished:
      dateModified:
      pageStart:185
      pageEnd:194
      sameAs:https://doi.org/10.1007/BF01834624
      keywords:
         breast cancer
         metastasis
         phospholipids
         fatty acids
         stearic acid
         Oncology
      image:
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:20
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Philippe Bougnoux
            affiliation:
                  name:CNRS URA 1334 et Faculté de Médecine
                  address:
                     name:Laboratoire de Biologie des Tumeurs, CNRS URA 1334 et Faculté de Médecine, Tours cedex, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Véronique Chajes
            affiliation:
                  name:CNRS URA 1334 et Faculté de Médecine
                  address:
                     name:Laboratoire de Biologie des Tumeurs, CNRS URA 1334 et Faculté de Médecine, Tours cedex, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Monique Lanson
            affiliation:
                  name:CNRS URA 1334 et Faculté de Médecine
                  address:
                     name:Laboratoire de Biologie des Tumeurs, CNRS URA 1334 et Faculté de Médecine, Tours cedex, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kamel Hacene
            affiliation:
                  name:Centre René-Huguenin
                  address:
                     name:Dept. de Biostatistiques, Centre René-Huguenin, Saint-Cloud, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gilles Body
            affiliation:
                  name:CHU
                  address:
                     name:Clinique Gynécologique et Obstétricale, CHU, Tours, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Charles Couet
            affiliation:
                  name:CHU
                  address:
                     name:Laboratoire de Nutrition, CHU, Tours, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Olivier Le Floch
            affiliation:
                  name:CHU
                  address:
                     name:Clinique d'Oncologie et Radiothérapie, CHU, Tours, France
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:20
Organization:
      name:Kluwer Academic Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:CNRS URA 1334 et Faculté de Médecine
      address:
         name:Laboratoire de Biologie des Tumeurs, CNRS URA 1334 et Faculté de Médecine, Tours cedex, France
         type:PostalAddress
      name:CNRS URA 1334 et Faculté de Médecine
      address:
         name:Laboratoire de Biologie des Tumeurs, CNRS URA 1334 et Faculté de Médecine, Tours cedex, France
         type:PostalAddress
      name:CNRS URA 1334 et Faculté de Médecine
      address:
         name:Laboratoire de Biologie des Tumeurs, CNRS URA 1334 et Faculté de Médecine, Tours cedex, France
         type:PostalAddress
      name:Centre René-Huguenin
      address:
         name:Dept. de Biostatistiques, Centre René-Huguenin, Saint-Cloud, France
         type:PostalAddress
      name:CHU
      address:
         name:Clinique Gynécologique et Obstétricale, CHU, Tours, France
         type:PostalAddress
      name:CHU
      address:
         name:Laboratoire de Nutrition, CHU, Tours, France
         type:PostalAddress
      name:CHU
      address:
         name:Clinique d'Oncologie et Radiothérapie, CHU, Tours, France
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Philippe Bougnoux
      affiliation:
            name:CNRS URA 1334 et Faculté de Médecine
            address:
               name:Laboratoire de Biologie des Tumeurs, CNRS URA 1334 et Faculté de Médecine, Tours cedex, France
               type:PostalAddress
            type:Organization
      name:Véronique Chajes
      affiliation:
            name:CNRS URA 1334 et Faculté de Médecine
            address:
               name:Laboratoire de Biologie des Tumeurs, CNRS URA 1334 et Faculté de Médecine, Tours cedex, France
               type:PostalAddress
            type:Organization
      name:Monique Lanson
      affiliation:
            name:CNRS URA 1334 et Faculté de Médecine
            address:
               name:Laboratoire de Biologie des Tumeurs, CNRS URA 1334 et Faculté de Médecine, Tours cedex, France
               type:PostalAddress
            type:Organization
      name:Kamel Hacene
      affiliation:
            name:Centre René-Huguenin
            address:
               name:Dept. de Biostatistiques, Centre René-Huguenin, Saint-Cloud, France
               type:PostalAddress
            type:Organization
      name:Gilles Body
      affiliation:
            name:CHU
            address:
               name:Clinique Gynécologique et Obstétricale, CHU, Tours, France
               type:PostalAddress
            type:Organization
      name:Charles Couet
      affiliation:
            name:CHU
            address:
               name:Laboratoire de Nutrition, CHU, Tours, France
               type:PostalAddress
            type:Organization
      name:Olivier Le Floch
      affiliation:
            name:CHU
            address:
               name:Clinique d'Oncologie et Radiothérapie, CHU, Tours, France
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Laboratoire de Biologie des Tumeurs, CNRS URA 1334 et Faculté de Médecine, Tours cedex, France
      name:Laboratoire de Biologie des Tumeurs, CNRS URA 1334 et Faculté de Médecine, Tours cedex, France
      name:Laboratoire de Biologie des Tumeurs, CNRS URA 1334 et Faculté de Médecine, Tours cedex, France
      name:Dept. de Biostatistiques, Centre René-Huguenin, Saint-Cloud, France
      name:Clinique Gynécologique et Obstétricale, CHU, Tours, France
      name:Laboratoire de Nutrition, CHU, Tours, France
      name:Clinique d'Oncologie et Radiothérapie, CHU, Tours, France
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(86)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.08s.